Baicheng Pharmaceutical: Signed a "Technology Development Cooperation Agreement" with Zhejiang Zhongshen Innovative Medical Technology.

Notice from Baicheng Pharmaceuticals: The company has reached an exclusive licensing cooperation agreement with Zhejiang Zhongshen Innovative Pharmaceutical Technology Co., Ltd. on the innovative drug BIOS-0629 project in the Greater China region, and signed a "Technology Development Cooperation Agreement" and supplementary agreement. The cooperation agreement will take effect after approval by the company's shareholders' meeting. The transaction price is 300 million yuan. Mr. Feng Enguang, the legal representative and senior management of Zhongshen Innovation, was the former deputy general manager of the company, so the transaction with Zhongshen Innovation constitutes a related party transaction.